𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data

✍ Scribed by Calogero Cammà; Marco Giunta; Liliana Chemello; Alfredo Alberti; Hidenori Toyoda; Christian Trepo; Patrick Marcellin; Friederike Zahm; Solko Schalm; Antonio Craxì

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
100 KB
Volume
30
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

the other members of the European Concerted Action on Viral Hepatitis Group are listed in the Appendix.

📜 SIMILAR VOLUMES

Effect of peginterferon alfa-2a on liver
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: A meta-analysis of individual patient data
✍ Calogero Cammà; Danilo Di Bona; Filippo Schepis; E. Jenny Heathcote; Stefan Zeuz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

Multicenter randomized trials have shown that once-weekly pegylated interferon (peginterferon) alfa-2a is more efficacious than conventional interferon alfa-2a (IFN) in patients with chronic hepatitis C. We performed a meta-analysis of 1,013 previously untreated patients (from 3 randomized trials) w

Pegylated interferon monotherapy of chro
Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials
✍ Fabrizio Fabrizi; Vivek Dixit; Piergiorgio Messa; Paul Martin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract The efficacy and safety of pegylated interferon monotherapy in patients with chronic renal failure and chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue. A systematic review of the literature with a meta‐analysis of

Meta-analysis: Reduced incidence of hepa
Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C
✍ Yasuhiro Miyake; Yoshiaki Iwasaki; Kazuhide Yamamoto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 252 KB 👁 1 views

## Abstract Interferon treatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma (HCC) in sustained responders. However, estimation of the effect of interferon treatment on HCC development in nonresponders is yet to be fully implemented. We conducted a meta‐analysis of 3 r

The effect of retreatment with interfero
The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
✍ Hidenori Toyoda; Takashi Kumada; Satoshi Nakano; Isao Takeda; Keiichi Sugiyama; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those

Cognitive function does not worsen durin
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C
✍ Robert J. Fontana; Linas A. Bieliauskas; Karen L. Lindsay; Carla Back-Madruga; E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

and the HALT-C Trial Group Treatment of chronic hepatitis C with pegylated interferon (peginterferon) and ribavirin can cause or exacerbate depression but its effects on cognitive function are largely unknown. The aim of this study was to determine whether treatment with peginterferon and ribavirin